Back to search
FDAFDA · Food and drugs·Recall number Z-2627-2019

SHERPA NX ACTIVE GUIDING CATHETER, 6F ERAD LEFT, .070", REF SA6ERADL. for cardiovascular use

Published October 9, 2019 · Recall initiated: March 15, 2019

Summary

FDA records medical device Class I recall Z-2627-2019, published October 9, 2019 and initiated March 15, 2019. Recalling firm: Medtronic Vascular; Status: Completed; Reported quantity: 167 units; Lot: GTIN: 00613994824769 All Lot/Serial Numbers. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Medtronic Vascular
Distributor
Worldwide distribution to US, Austria, Belgium, Bulgaria, Czech Republic, France, Germany, Greece, Hong Kong, Ireland, Italy, Kazakhstan, Luxembourg, Moldova, Netherlands, Poland, Portugal, Russian Federation, Saudi Arabia, Slovakia, South Africa, Spain, Sweden, Taiwan, and United Kingdom
Lot
GTIN: 00613994824769 All Lot/Serial Numbers
Risk classification
Class I
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was SHERPA NX ACTIVE GUIDING CATHETER, 6F ERAD LEFT, .070", REF SA6ERADL. for cardiovascular use recalled?

Yes. FDA published recall Z-2627-2019 on October 9, 2019. Reported hazard: There is a potential for extensive loss of primary segment material exposing underlying stainless-steel braid wires on a subset of 6F Sherpa catheters.

What should I do if I have this product?

Voluntary: Firm initiated · Letter